Dipal Doshi - 28 Oct 2021 Form 3 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
President and CEO, Director
Signature
/s/ Jared Cohen, as Attorney-in-fact
Issuer symbol
TRDA
Transactions as of
28 Oct 2021
Transactions value $
$0
Form type
3
Filing time
28 Oct 2021, 20:50:25 UTC
Next filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TRDA Common Stock 174K 28 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TRDA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 410K $1.74 Direct F2
holding TRDA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 140K $2.10 Direct F3
holding TRDA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 313K $8.47 Direct F4
holding TRDA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 82.9K $12.52 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 156,465 shares of common stock and (ii) 17,995 shares of restricted common stock issued upon early exercise of stock options.
F2 25% of the shares subject to this option vested and became exercisable on December 31, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F3 25% of the shares subject to this option shall vest and become exercisable on August 12, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F4 25% of the shares subject to this option shall vest and become exercisable on March 30, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F5 25% of the shares subject to this option shall vest and become exercisable on August 2, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney